Title : Conophylline Suppresses Angiotensin II-Induced Myocardial Fibrosis In Vitro via the BMP4/JNK Pathway.

Pub. Date : 2021 Jul

PMID : 34302205






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conophylline Suppresses Angiotensin II-Induced Myocardial Fibrosis In Vitro via the BMP4/JNK Pathway. conophylline bone morphogenetic protein 4 Rattus norvegicus
2 Conophylline did not affect the TGF-beta pathway altered by angiotensin II, but markedly decreased the level of bone morphogenetic protein-4 (BMP4) enhanced by angiotensin II and BMP4 itself. conophylline bone morphogenetic protein 4 Rattus norvegicus
3 Conophylline did not affect the TGF-beta pathway altered by angiotensin II, but markedly decreased the level of bone morphogenetic protein-4 (BMP4) enhanced by angiotensin II and BMP4 itself. conophylline bone morphogenetic protein 4 Rattus norvegicus
4 Conophylline did not affect the TGF-beta pathway altered by angiotensin II, but markedly decreased the level of bone morphogenetic protein-4 (BMP4) enhanced by angiotensin II and BMP4 itself. conophylline bone morphogenetic protein 4 Rattus norvegicus
5 Conophylline produced no effect on phosphorylation of alpha-SMA and Smad homologue-1/5/8, the classic BMP4 downstream pathway elements, but reduced the level of c-Jun N-terminal kinase (JNK) elevated by BMP4. conophylline bone morphogenetic protein 4 Rattus norvegicus
6 Thus, conophylline inhibited angiotensin II-provoked myocardial fibrosis via the BMP4/JNK pathway. conophylline bone morphogenetic protein 4 Rattus norvegicus